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Specificity in mineralocorticoid versus glucocorticoid action. extent and molecular basis of this overlap of mineralo-
The mineralocorticoid receptor (MR) and the glucocorticoid corticoid and glucocorticoid actions have been the sub-
receptor (GR) share considerable structural and functional ject of both debate and speculation for many years [3–9].homology. Overlapping effects on epithelial sodium transport
The MR is expressed at the greatest abundance inare observed in vivo; in vitro, both are able to bind and trans-
the sodium-transporting epithelia of the distal colon andactivate through a common hormone response element. This
has led several investigators to suggest that specificity is con- distal nephron [3, 4], in certain regions of the central
ferred primarily by prereceptor mechanisms, and we have ad- nervous system, particularly the hippocampus [10], and
dressed this question using both in vitro and in vivo approaches. at lower abundance in a variety of other tissues. TheAlthough the MR has been regarded as less transcriptionally
glucocorticoid receptor (GR) shows considerable structuralactive than the GR in vitro, significant differences are observed
(Fig. 1) and functional homology with the MR [11, 12].when epithelial rather than fibroblast cell lines are used. These
differences are mediated by the N-termini of the receptors. Acti- The GR, which is expressed relatively ubiquitously, me-
vation of intracellular signaling pathways differentially modu- diates a diverse range of effects, including increased elec-
lates MR- versus GR-mediated transactivation. Although these
trolyte transport. The distinction mineralocorticoid:gluco-studies identify mechanisms by which specificity may be achieved,
corticoid is confounded by the fact that, while aldosteronethey do not prove that this occurs in vivo. Such studies have
been limited by an absence of MR-regulated genes. Known binds to the GR with an affinity several orders of magni-
candidate aldosterone-responsive genes have been examined tude lower than that with which it binds to the MR,
in the rat distal colon; the time course and the specificity of cortisol binds to the MR with a higher affinity than to
the response to a single parenteral dose of corticosteroid has
the GR [11, 12]. Given that cortisol circulates at muchbeen characterized. The epithelial sodium channel b and g
higher concentrations than aldosterone, cortisol wouldsubunit genes are both up-regulated within 60 minutes by either
MR or GR activation. Similar responses are observed for the be expected to fully occupy the MR under most condi-
serum and glucocorticoid-regulated kinase and channel-induc- tions. It is now well established that specificity of receptor
ing factor genes. All four genes show clear and rapid up-regula- occupancy is achieved at a prereceptor level by the juxta-tion of their mRNA levels by aldosterone, which is paralleled
position of the type II isoform of the enzyme 11b-hydroxy-by GR-mediated up-regulation of expression. While they are
steroid dehydrogenase (11b-HSD2) with the MR inindeed aldosterone-responsive genes, genes that are uniquely
aldosterone-regulated remain to be identified. epithelial cells [13, 14]. 11b-HSD2 converts cortisol to
cortisone (or corticosterone to 11-dehydrocorticosterone
in rodents). Cortisone is inactive with respect to both
Aldosterone plays a central role in the control of blood the MR and the GR.
pressure as a result of its effects on sodium homeostasis. As for the androgen and progesterone receptors, the
In addition, it has both direct and indirect effects on potas- MR can regulate gene expression, at least in an in vitro
sium and hydrogen ion homeostasis. These mineralocorti- system, by binding to a glucocorticoid response element
coid actions are mediated by the binding of aldosterone (GRE) in the promoter of a reporter gene (Fig. 2), such
to the mineralocorticoid receptor (MR), a member of as the often used mouse mammary tumor virus (MMTV)
the steroid/thyroid/retinoid superfamily of ligand-depen- promoter [11, 12]. This apparent lack of specificity with
dent transcription factors [1, 2]. The physiological gluco- respect to DNA binding has led various authors to argue
corticoid cortisol also has effects on epithelial electrolyte that mineralocorticoid versus glucocorticoid specificity
transport and the maintenance of blood pressure. The is entirely prereceptor [6, 7]. Under this scheme, physio-
logical specificity relies on a combination of the patterns
of corticosteroid receptor and 11b-HSD2 expression. In
1 Present address: Imperial Cancer Research Fund, PO Box 123, 44 the experimental situation, specificity can be expandedLincoln’s Inn Fields, London WC2 A 3PX, United Kingdom.
to include ligand specificity caused by the use of synthetic
Key words: aldosterone, dexamethasone, cortisol, sodium transport. ligands, which putatively bind only MR or GR, be they
agonist or antagonist.Ó 2000 by the International Society of Nephrology
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Fig. 1. Schematic representation of the struc-
tures of the human mineralocorticoid receptor
(MR) and glucocorticoid receptor (GR) with
the percentage amino acid identity between
each of the domains shown (adapted with per-
mission from Arriza et al in Science [11]).
This review seeks to address this issue from both a The time course of the response in any of these tissues
is important, particularly if one wishes to correlate physi-conceptual or inferential perspective, and also with re-
gard to studies of aldosterone-induced gene expression. ological and molecular responses. Verrey has recently
reviewed this issue in some detail [19]. In brief, aldoste-The first section is an overview of the mineralocorticoid
rone action mediated via the MR may be divided intoresponse in vivo as reported in studies in which the issue
early effects with an onset of 30 to 60 minutes afterof specificity has been specifically addressed. This is con-
aldosterone administration and late effects with a timetrasted with studies in cell culture systems in which speci-
of onset of three to six hours. The early response isficity is not observed. Our own studies, as well as those
characterized by an increased amiloride-sensitive electro-of others, using in vitro systems are discussed with re-
genic sodium flux through the sodium channels in thespect to molecular mechanisms by which specificity may
apical membrane. During the later phase, there is accu-be achieved. Finally, we present recent data on the regu-
mulation of sodium channels and pumps [19]. Most stud-lation by corticosteroids of the expression of putative
ies of mineralocorticoid physiology commence at andaldosterone-induced genes in vivo.
often beyond three to six hours, so that back extrapola-
tion to primary molecular events may be inappropriate.
MINERALOCORTICOID PHYSIOLOGY Superficially, there are clear differences between GR
In examining the studies of the physiology of aldoste- and MR activation seen most graphically when the clini-
rone action, it is important to consider both the tissue cal syndromes of aldosterone and cortisol excess, Conn’s
in which the response is being characterized and the and Cushing’s syndromes, respectively, are compared.
time course of the response. Amphibian systems have Similarly, when receptor function is lost, as in the MR-
provided very important insights into mineralocorticoid and GR-knockout mice, the phenotypes are distinctly
physiology, particularly the toad bladder and more re- different [20, 21]. At least some of the differences seen
cently the A6 renal epithelial cell line [15]; however, as in these in vivo situations may simply reflect differences
discussed later in this article, there are certain caveats in the tissue distribution of the receptor.
that must be placed on the interpretation of these studies. Turnamian and Binder have directly addressed the
In mammalian systems, most studies are of either the question of MR versus GR action on electrolyte trans-
port in rat distal colon [5]. They infused synthetic MR-kidney or the distal colon. The distal nephron of the
kidney is a complex epithelium with clear partitioning or GR-specific steroids for up to 11 days and character-
ized the resulting changes in specific transport processes.of function, including mineralocorticoid responses. The
distal colon is, in contrast, a relatively simple epithelium They found that, although the MR agonist induced elec-
trogenic amiloride-sensitive sodium absorption with in-in which the actions of mineralocorticoids are well de-
scribed [4]. There is an assumption that the mechanisms hibition of electroneutral Na-Cl absorption, the GR ago-
nist induced only electroneutral Na-Cl absorption. Inof the colonic response are analogous to those of the
distal nephron, but this is by no means certain, and tissue- contrast to the synthetic mineralocorticoid, the glucocor-
ticoids also failed to increase active potassium transport.specific differences at both physiological and molecular
levels have been identified [3, 4, 16–18]. Caution must These authors argued that previous studies using less
receptor-selective agonists such as dexamethasone werebe applied when drawing general conclusions about spec-
ificity from studies in any one system. Our in vivo studies confounded by cross-over receptor activation, particu-
larly at higher concentrations. Bastl and Hayslett simi-have focused on the distal colon, and many of the physio-
logical studies that have sought to address MR versus larly concluded that glucocorticoids acted primarily to
increase electroneutral sodium transport in distal colon,GR specificity have used this system.
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Fig. 2. Schematic representation of the primary regulation of genes by the MR and the GR. Prereceptor specificity is provided by 11b-hydroxysteroid
dehydrogenase (11b-HSD2). In most systems, both the MR and the GR can transactivate at a simple glucocorticoid receptor element (GRE),
whereas specificity has been reported at a composite GRE through an interaction with the activator protein-1 (AP-1) complex [38]. An analogous
mechanism that confers MR specificity remains to be identified.
with regulation of electrogenic transport being mediated salt replacement enables them to be rescued [27]. Al-
by the MR [4]. Lomax and Sandle reported increased though this may reflect adverse effects of the high doses
apical Na1 conductance in the distal colon of adrenalec- of glucocorticoid, it may also imply that GR activation
tomized rats after seven days of aldosterone or pure syn- cannot fully compensate for the lack of MR function [27].
thetic glucocorticoid treatment, whereas increased apical
K1 conductance was only observed after aldosterone
STUDIES USING CELLS IN CULTUREtreatment [22]. These studies have conclusively shown
Studies in vitro using either cell lines or primary cul-that in the distal colon, MR but not GR mediates in-
tures of isolated cells have supported the conclusion thatcreased K1 transport, whereas both MR and GR en-
the postreceptor events are indeed nonselective with re-hance Na1 transport albeit through different pathways.
gard to MR versus GR. Husted, Laplace, and StokesThe time courses of these studies, however, may have
reported that 24-hour exposure to both MR- and GR-allowed secondary effects of the steroids [23] acting on
selective agonists could stimulate electrogenic sodiumother tissues or pathways to have contributed to the
transport in rat inner medullary collecting duct cells [28].observed changes in electrolyte transport.
In a subsequent study, the same authors found differ-Fromm, Schulzke, and Hegel used isolated rat distal
ences in the time course of the response mediated by thecolon to examine Na1 absorption over eight hours of
two receptors, it being more prompt after glucocorticoidsteroid treatment [24]. An increase in electrogenic Na1
treatment [29]. On the basis of this and other observa-absorption was observed at two hours. In contrast to
tions, the authors concluded that the MR and the GRprevious studies, this group reported increased electro-
activate different but overlapping cellular events leadinggenic absorption in response to the pure glucocorticoid
to sodium transport [29]. Several of the cellular responsesRU28362 [9]. These authors argued against MR:GR
differed from those reported for cortical collecting ductspecificity and emphasized the possible role of GR:MR
cells, which suggests significant segmental differences inheterodimerization in the response [25, 26]. Funder et
responses within the nephron [29]. Na´ray-Fejes-To´th andal observed a similar acute antinatriuretic response to
Fejes-To´th used immunodissected rabbit cortical collect-activation of either the GR or MR using a Kagawa bio-
ing duct cells to demonstrate that both transepithelial po-assay, which led these authors to also conclude that MR
tential difference and short-circuit current were increasedversus GR selectivity is entirely prereceptor [7].
by aldosterone and a selective glucocorticoid agonist [6].Berger et al have recently reported the phenotype of
In this study, all of the cellular events measured exhibitedtransgenic mice in which a null mutation in the MR gene
a similar response to both classes of steroid.has been created by homologous recombination [20].
A6 cells, which are derived from Xenopus laevis renalThese mice show features of severe mineralocorticoid de-
tubules, have been used extensively for studies of miner-ficiency, with marked salt wasting and dehydration. They
alocorticoid responsivity. Their mineralocorticoid responsedo not survive beyond eight days. Treatment with the
to both aldosterone and glucocorticoids is mediated viasynthetic glucocorticoid betamethasone prolongs sur-
vival, but the mice ultimately succumb, whereas careful the GR, as the endogenous MR is inactive [30, 31], which
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suggests that some caution is required when extrapolat- [38]. The use of a DNA-binding mutation of the GR in
transgenic mice has further confirmed the importance ofing studies from this amphibian cell line to the mamma-
lian kidney. Nakhoul et al and Bens et al have recently protein:protein interactions independent of GR-DNA
binding in GR-mediated gene expression [35]. Identifi-described the responses of two murine transformed renal
cortical collecting duct cell lines to corticosteroids [32, 33]. cation of a MR-regulated gene or genes in vivo would
clearly facilitate the characterization of the molecularIn both lines, aldosterone induced amiloride-sensitive
electrogenic sodium transport; however, in neither were basis of mineralocorticoid-specific regulation; however,
MR-regulated genes have been identified only recently,highly selective GR agonists examined. Further studies
of the response of one or both of these lines to selective and in all cases, these genes also appear to be GR-
regulated, as discussed later in this article. An alternateMR and GR agonists will be of considerable interest.
approach, in the absence of specifically MR-responsive
promoters, is to identify the mechanisms by which MR-
TRANSFECTION STUDIES
specific regulation may be achieved, at least under in
The observation in cotransfection experiments that vitro conditions.
both the MR and the GR can transactivate at GRE In the classic cis-trans assay [11, 12] using the trans-
sequences, particularly those of the MMTV promoter fected human GR or MR with MMTV luciferase (LUC)
[11, 12], lent credence to the argument that the GR and or MMTV chloramphenicol acetyl transferase (CAT) as
MR, once activated, exert equivalent effects (Fig. 2). The a reporter gene in CV-1 cells, the MR exhibits approxi-
DNA-binding domains of the MR and the GR share mately 20% of the maximal response of the GR [39].
94% identity [11], so this finding is not unexpected. MR- Creation of chimeric receptors between the MR and the
mediated transactivation at other “physiologically rele- GR demonstrated that this difference was located in the
vant” promoters has been reported. Zennaro, Le Men- N-terminal domains of the receptors [39], a somewhat
uet, and Lombe`s reported that the more distal of the unsurprising finding given that (1) this region shows ,15%
two major promoters of the human mineralocorticoid identity between the receptors [11], and (2) that it con-
receptor (hMR) gene was induced by both the MR and tains the major activation function (AF-1) for this system.
the GR [34]; interestingly, the region of the promoter CV-1 cells are a fibroblast-derived cell line; when we ex-
through which this effect was mediated does not contain amined the response in cell lines of either epithelial (LLC-
an obvious GRE. This promoter is primarily used for PK1) or hippocampal (RN33B) origin (Fig. 3), the relative
MR gene expression in the central nervous system, and levels of maximal MR-mediated transactivation doubled
since corticosteroid regulation of receptor levels has [40]. Again using chimeric receptors, we were able to
been clearly demonstrated in the central nervous system show that the effect was mediated by the N-terminal do-
as opposed to peripheral tissues, the finding is therefore main. This suggested to us that cell-specific factors such
potentially of physiological significance. It suggests that, as coactivators or corepressors are likely to interact very
as with some actions of the GR [35], transactivation of the differently with the respective AF-1 regions of the two
MR gene may be mediated via nonclassic albeit genomic receptors [41]. It follows that as for the GR [38], there
mechanisms, and furthermore, as for classic GRE trans- is no reason a priori why MR-specific transactivation might
activation, there may be an overlap of MR- and GR- not occur. We reasoned that not only might cell-specific
mediated effects. Although the studies found similar re- profiles of transcription factors/coactivators be important
sults in both CV-1 cells and a renal cortical cell line in defining GR versus MR specificity, but that, as with
[34], it may be that a hippocampal cell line is needed to the GR and AP-1 interaction, activation of cell signaling
explore specificity at this promoter fully. pathways may contribute to MR specificity. Using the
Derfoul et al have reported MR-mediated transactiva- LLC-PK1 cells and the MMTV promoter, the relative
tion at the human Na,K-ATPase b1 gene promoter [36]. transactivation by transfected MR and GR was examined
A response element was identified within the promoter in the presence of various activators of cell surface recep-
that responds both to activated MR and GR in CV-1 tors and/or signaling pathways [42]. Whereas treatment
cells [36]. Although it is clear that this gene is regulated with 8 bromo-cAMP enhanced transcription by both re-
under physiological conditions by glucocorticoids with a ceptors, as has been reported elsewhere [43], the addition
relatively short time course, this has been demonstrated of the phosphatase inhibitor okadaic acid enhanced GR-
not to occur with aldosterone in a mammalian system but not MR-mediated transcription. Dose-response stud-
in vivo [37]. Thus, this natural, physiologically relevant ies with okadaic acid suggested that serine/threonine
promoter did not exhibit receptor specificity under the protein phosphatase 1 is involved in GR- but not MR-
conditions of the transfection. mediated transactivation [42]. For the GR, this is consis-
Pearce and Yamamoto demonstrated in vitro that at tent with the effects of 8 bromo-cAMP alone, whereas
least one action of the GR, interaction with the AP-1 in the case of the MR, phosphorylation/dephosphoryla-
tion of another factor or of the MR itself must be invokedcomplex at a composite GRE, was GR-specific (Fig. 2)
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a2-adrenergic agonist UK14304. Both of these inhibited
MR-mediated transactivation but were without signifi-
cant effect on the GR, although in both cases, there
was a trend toward increased transactivation. The exact
mechanism of the verapamil effect is unclear, as both a
calcium ionophone and a calmodulin kinase inhibitor
were without effect. UK14304 has effects on several
pathways. Clonidine was without effect, although, unlike
UK14304, it is only a partial a2-adrenergic agonist. The
precise mechanism of these differential effects remains
to be resolved; however, given the evidence suggesting
a specific role for the MR in the central regulation of
blood pressure, we speculated that the antihypertensive
effect of these agonists might at least in part be mediated
via inhibition of MR-specific transactivation [42].
The possibility of interactions between members of the
gene superfamily of nuclear receptors was also examined
[42]. Using the same system but with cotransfection of
the thyroid hormone receptor (TR), activated TR was
found to inhibit both MR- and GR-mediated transactiva-
tion. However, in the absence of thyroid hormone, only
MR-mediated transactivation was inhibited, albeit to a
lesser extent. The reverse was also observed in that the
MR without ligand inhibited TR-mediated transactiva-
tion at a thyroid-response element. Whether this repre-
sents a direct interaction between the MR and the TR
or competition for a limiting cellular factor is not clear.
The critical significance of these studies is the clear
demonstration that under appropriate conditions both
MR- and GR-specific mediation of corticosteroid-induced
transactivation can occur, even at a relatively nonspecific
promoter. From the studies of Pearce and Yamamoto,
receptor-specific interactions with other cellular factors
clearly can also be exploited at noncanonical hormone
response elements [38]. In the absence of clearly defined
aldosterone-responsive genes and/or uniquely aldosterone-
responsive promoters, these concepts, however, remain
just that. MR versus GR specificity is, in principle, an
issue only where the MR and GR are coexpressed. Spe-
cific effects must therefore be distinguished using recep-
tor-specific ligands. Under physiological conditions, both
receptors may be activated which may result in MR:GR
heterodimers [25, 26, 36]. In CV-1 cells, this interactionFig. 3. Cellular variations in relative GR and MR responses. The dose–
response curves to cortisol for the GR (s) and the MR (d) in each of inhibits GR-mediated transactivation [25, 36], but in SK-
three cell lines is shown (reprinted with permission from Lim-Tio, N-MC cells using an MMTV promoter, an enhancedKeightley and Fuller, and Endocrinology [40]).
transcriptional response was observed [26]. Such interac-
tions may clearly confound analysis of specificity.
[44]. Other agents were examined in the system including
SPECIFICITY OF REGULATION OF GENEthe phorbol ester, phorbol 12-myristate 13-acetate (PMA),
EXPRESSION IN VIVOwhich was without effect on transcription by either recep-
The preceding discussion is clearly hypothetical in thetor, and sodium nitroprusside, which enhanced GR- but
absence of clearly defined aldosterone-responsive genes.not MR-mediated transactivation. Two agents, however,
Identification of genes that are regulated in vivo by aldo-were found to exhibit MR-specific effects, the calcium
channel blocker verapamil and the clonidine analog and sterone has proven elusive [19, 45].
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Fig. 4. Time course of the increase in mRNA
levels in response to a single parenteral dose
of aldosterone (A) or dexamethasone (B). The
results of studies of the expression of the
CHIF [60], sgk (Brennan and Fuller, unpub-
lished data), and ENaC subunit (Fuller et al,
unpublished data) genes have been plotted
relative to control levels. The results are de-
rived from Northern blot analysis of total co-
lonic RNA taken at 0, 0.5, 1, 2, and 4 hours
after a single injection of steroid (aldosterone
50 mg/kg, intraperitoneally, or dexamethasone
0.5 ng/kg, intramuscularly). The CHIF (r),
sgk (h), aENaC (j), bENaC (d), and gENaC
(m) mRNA levels (as a ratio of GAPDH
mRNA) are expressed as the mean 6 SEM.
Essential to the characterization of MR versus GR this central role of the ENaC in the mineralocorticoid
response, it follows that aldosterone may induce expres-specificity is the identification of genes that are regulated
by corticosteroids as part of the physiological mineralo- sion of the subunit genes or proteins that modify some
property of existing channels to increase their open prob-corticoid response. Such genes need to be primary re-
sponse genes [23]. In addition, it follows that the re- ability [45, 47–49]. A number of studies have shown that
the ENaC subunit genes are regulated in a differentialsponse should occur in an acute time frame. Verrey has
very clearly articulated the temporal basis of the mineral- and tissue-specific manner [16–18]. Most of these studies
have examined the response to either aldosterone orocorticoid response [19]. The earliest physiological re-
sponse is seen with a latency of 30 to 60 minutes during dexamethasone over several hours or days. In the rat
distal colon, these studies have consistently demonstratedwhich primary response genes are being induced.
We have sought to identify genes that are regulated elevated bENaC and gENaC but not aENaC mRNA
levels in response to corticosteroids or an elevation ofacutely by aldosterone in vivo in the distal colon. Our
attempts to identify such genes using differential hybrid- endogenous aldosterone levels by salt restriction [16–18].
These studies have not, however, defined the time courseization, subtractive hybridization, and differential dis-
play have been unrewarding. In part, this may reflect of the response. We have examined the acute response
of the ENaC subunit genes in the rat distal colon to athe fact that an extremely small number of the total
genes expressed in distal colon are regulated, that the single parenteral dose of aldosterone, dexamethasone,
or the GR-specific ligand RU28362 (Fuller, Brennan,degree of regulation is probably relatively modest 60
minutes after a single dose of aldosterone, and that the and Burgess, manuscript submitted). aENaC mRNA
levels were unaltered by either aldosterone or dexameth-use of an in vivo system still presents substantial difficul-
ties in interpretation when compared with in vitro sys- asone treatment (Fig. 4). As in the previous longer term
studies, both the bENaC and gENaC subunit genes re-tems. In the last few years, several candidate genes have
emerged from studies by other groups, and we have sponded to aldosterone with a significant increase being
seen by 30 minutes (Fig. 4A). Both subunits also re-characterized the acute responses of four of these genes
to corticosteroids in the rat distal colon (Fig. 4). sponded to dexamethasone with the response being sig-
nificant at 60 minutes (Fig. 4B). RU28362 also inducedThe central role of the apical sodium channel in aldo-
sterone-mediated epithelial sodium transport is now both subunits, indicating that activation of the GR as
well as the MR can induce this response. When theclearly established through both electrophysiological and
molecular genetic studies [45–47]. The amiloride-sensi- baseline levels of bENaC and gENaC mRNA in the
distal colon of untreated adrenalectomized rats weretive epithelial sodium channel subunit genes (a, b, and
gENaC) were cloned from the rat distal colon [48, 49]. compared with the levels in intact rats, no significant
difference was observed. It remains to be shown thatThe three homologous subunits are arranged in a hetero-
tetrameric complex of two a and one each of the b and the observed responses are indeed primary responses;
however, they certainly occur within the appropriateg subunits [50]. Coexpression in Xenopus oocytes of
all three subunits is required for maximal electrogenic time frame. There does not appear to be a clear differ-
ence between MR and GR activation, aside from asodium flux [49], which is reflected in coexpression of
the three subunits in a variety of tissues [51]. Given slightly delayed response to dexamethasone relative to
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aldosterone. This may reflect different modes of adminis-
tration (intraperitoneally vs. intramuscularly) and/or the
differing pharmakokinetics of the two steroids. A func-
tional GRE has been reported in the human aENaC
promoter [52], which may mediate the response of this
subunit to glucocorticoid in the lung and possibly in
segments of the renal tubule. These same authors were,
however, unable to identify a functional/structural ste-
roid response element in either 450 or 800 bases of the
59 flanking regions of the hcENaC and rcENaC genes,
respectively [53, 54].
Two other genes, recently identified by differential
cloning strategies, are also regulated acutely by cortico-
steroids in the distal colon. Chen et al applied a sup-
pressive subtractive hybridization strategy to identify
acutely regulated genes in amphibian A6 cells after a
corticosteroid stimulus [55]. The cells were treated with
Fig. 5. Effect of cycloheximide on sgk mRNA expression in responsedexamethasone or vehicle for one hour prior to RNA to aldosterone. The results are derived from Northern blot analysis of
extraction. One of the genes identified by subtraction of total colonic RNA taken at 30 (h) and 60 ( ) minutes after a single
injection of aldosterone (Aldo). Cycloheximide (Cyclo) was adminis-the RNA was found to be the Xenopus homologue of
tered 30 minutes prior to the steroid. mRNA levels are given relativethe serum and glucocorticoid-regulated kinase (sgk), a
to control levels, as a ratio of GAPDH mRNA, and are expressed as
serine-threonine kinase identified previously by Webster mean 6 SEM (N 5 4). *P , 0.05.
et al [56]. Chen et al provided convincing evidence that
this is indeed a primary response gene in A6 cells [55],
and Na´ray-Fejes-To´th et al have reported similar find-
previously in this article, this gene exhibited an acuteings in isolated cortical collecting duct cells [57]. Both
response to a single parenteral dose of either MR or GRgroups provided evidence that sgk may directly regulate
agonist in the distal colon (Fig. 4). The response wasENaC activity. We have extended these studies to char-
significant at 60 minutes for aldosterone and 2 hoursacterize the response in vivo. In this case, we saw a
for dexamethasone, and induction was also seen withresponse to adrenalectomy in both rat kidney and distal
RU28362 [60]. The response to aldosterone was also notcolon. Sgk mRNA levels responded to both aldosterone
inhibited by cycloheximide pretreatment of the rats [60].and dexamethasone (Fig. 4), with a significant increase
In distal colon after steroid treatment, Northern blotseen by 30 minutes in the colon and slower increases in
analysis revealed multiple higher transcripts that hybrid-the kidney (Brennan and Fuller, manuscript submitted).
ized with an intron probe [61]. The increase in primaryIn A6 cells, the response was superinduced by cyclohexi-
and/or partially processed CHIF transcript levels aftermide, suggesting that this is indeed a primary response
steroid treatment argues in favor of a transcriptionalgene. We also observed an enhanced response to aldoste-
response [61]. We also found that CHIF mRNA levelsrone in the colon when rats were pretreated with cyclo-
were decreased in the colon (but not the kidney) byheximide (Fig. 5). sgk mRNA levels were also increased
adrenalectomy and that the treatment of intact rats withby carbenoxolone treatment of intact but not adrenalec-
carbenoxolone sodium, an inhibitor of 11b-HSD2, in-tomized rats (Brennan and Fuller, manuscript submit-
creased CHIF levels [60]. This latter response impliested). sgk was also induced by dexamethasone in a range
that corticosteroid-induced CHIF and also sgk expres-of other tissues in which the GR, but not the MR, is
sion occurs in colonic epithelial cells that express 11b-expressed.
HSD2. In addition, this observation, coupled with theThe fourth gene is the channel-inducing factor (CHIF)
response to adrenalectomy, suggests that modulation ofgene, which was identified by Attali et al [58]. This gene
CHIF mRNA levels in the distal colon occurs at circulat-was differentially cloned from colonic RNA from rats
ing levels of corticosteroid.treated with high doses of dexamethasone for two days.
Another gene putatively involved in colonic potassiumAlthough the exact function of this gene is not certain,
transport, the a-subunit of the colonic H1-K1ATPase,it appears to be a transmembrane regulator or compo-
is regulated by two days of corticosteroid treatment [62].nent of potassium channels and/or pumps, and thus, its
However, using the experimental protocol described ear-role may be in the corticosteroid regulation of potassium
lier in this article, we have not observed acute regulationtransport independent of effects on sodium transport
of this gene by either aldosterone or dexamethasone[59]. CHIF is expressed in great abundance in distal
colon and kidney [59]. As with the other genes described (Verity and Fuller, unpublished observations).
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